من المتوقع أن يصل سوق خدمات التشريح المرضي إلى 35,187.90 مليون دولار أمريكي بحلول عام 2028 من 23,890.44 مليون دولار أمريكي في عام 2021؛ ومن المتوقع أن ينمو بمعدل نمو سنوي مركب قدره 5.7% من عام 2021 إلى عام 2028.
تُستخدم خدمات التشريح المرضي في الفحص المجهري للأنسجة البيولوجية في تشخيص الأمراض. بمساعدة تقنيات التصوير، يمكن الحصول على أنسجة الخزعة من مواقع معينة لا يمكن الوصول إليها، مثل البنكرياس والصفاق. عوامل مثل ارتفاع الطلب على المواد البيولوجية وزيادة انتشار الأمراض المزمنة تدفع نمو سوق خدمات التشريح المرضي. ومع ذلك، من المتوقع أن تؤدي القيود المرتبطة بعلم التشريح المرضي والكيمياء المناعية إلى تقييد نمو السوق إلى حد معين خلال الفترة المتوقعة.
المناطق المربحة لسوق خدمات علم التشريح المرضي
رؤى السوق
تزايد انتشار الأمراض المزمنة
الأمراض المزمنة مثل اضطرابات القلب والأوعية الدموية، والاضطرابات العصبية تعد اضطرابات المناعة الذاتية والسرطان السبب الرئيسي للوفاة والعجز في جميع أنحاء العالم. وفقًا لمراكز السيطرة على الأمراض والوقاية منها، في عام 2019، عانى ما يقرب من 6 من كل 10 أشخاص من مرض مزمن واحد على الأقل في الولايات المتحدة. وفقًا لمنظمة الصحة العالمية (WHO)، تعد أمراض القلب والأوعية الدموية السبب الأول للوفاة على مستوى العالم، حيث تودي بحياة ما يقدر بنحو 17.9 مليون شخص كل عام.
يعد السرطان أحد الأسباب الرئيسية للوفيات في جميع أنحاء العالم، والذي يشكل عبئًا ماليًا ضخمًا على المجتمع. وفقًا لمنظمة الصحة العالمية، في عام 2018، حدثت حوالي 9.6 مليون حالة وفاة بسبب السرطان على مستوى العالم. ومع ذلك، فإن الأبحاث المتزايدة حول تطوير علاجات فعالة لهذا المرض تؤثر على نمو السوق. وفقا للملف الصحي الوطني، زادت حالات السرطان الشائعة، بما في ذلك سرطان عنق الرحم والفم وسرطان الثدي، بنسبة 324٪ في الهند من عام 2017 إلى عام 2018. بالإضافة إلى ذلك، فإن العدد الإجمالي للمرضى الذين يزورون عيادات الأمراض غير المعدية (NCD) وقد تضاعفت بين عامي 2017 و2018، حيث سجلت 35 مليوناً و66 مليوناً على التوالي. يعد التغيير السريع في نمط الحياة واستهلاك الكحول ومنتجات التبغ من بين العوامل البارزة التي تزيد من حالات الإصابة بالسرطان بين السكان.
تساهم أمراض المناعة الذاتية أيضًا في إصابة عدد كبير من السكان بأنواع مختلفة من الأمراض. على سبيل المثال، وفقًا للمعاهد الوطنية للصحة، يعاني حوالي 23.5 مليون أمريكي من أمراض المناعة الذاتية، كما أن 8 ملايين شخص إضافي لديهم أجسام مضادة ذاتية في جزيئات الدم تشير إلى فرصة الشخص في الإصابة بأمراض المناعة الذاتية. لا يزال السبب الكامن وراء أمراض المناعة الذاتية المختلفة غير معروف. وبالتالي، يقوم الباحثون والمعالجون الذين يعالجون ويستكشفون علاجات هذه الأمراض بإجراء تحليل نسيجي مفصل لفهم آلية الأمراض وتصميم علاجات وعلاجات لإدارتها. وبالتالي، من المتوقع أن يكون العدد المتزايد من الأمراض المزمنة في جميع أنحاء العالم مسؤولاً عن نمو سوق خدمات التشريح المرضي خلال الفترة المتوقعة.
نوع الفحص - الرؤى القائمة على
استنادًا إلى نوع الفحص، يتم تصنيف سوق خدمات التشريح المرضي إلى عينات جراحية، وخزعة الثدي، وخزعة الرئة ، خزعة الكلى، خزعة الجهاز الهضمي، خزعة البنكرياس، خزعة أنسجة الجلد، خزعة الخصية وغيرها. في عام 2021، استحوذ قطاع العينات الجراحية على أكبر حصة من السوق ومن المتوقع أن ينمو بأسرع معدل خلال الفترة المتوقعة.
سوق خدمات التشريح المرضي العالمي، بواسطة نوع الفحص – 2021 و2028
رؤى مستندة إلى المستخدم النهائي
استنادًا إلى المستخدم النهائي، تم تقسيم سوق خدمات التشريح المرضي إلى مختبرات تشخيصية ومختبرات مرجعية ومعاهد بحثية وغيرها. في عام 2021، استحوذ قطاع المختبرات التشخيصية والمختبرات المرجعية على الحصة الأكبر من السوق ومن المتوقع أن ينمو بمعدل نمو سنوي مركب كبير خلال الفترة المتوقعة.
الرؤى الإستراتيجية< /h3>
تتبنى العديد من الشركات العاملة في سوق خدمات التشريح المرضي استراتيجيات مثل إطلاق المنتجات وعمليات الدمج والاستحواذ والتعاون وابتكارات المنتجات وتوسيع محفظة المنتجات لتوسيع تواجدها في جميع أنحاء العالم والحفاظ على اسم العلامة التجارية وتلبية الطلب المتزايد. من المستخدمين النهائيين.
سوق خدمات التشريح المرضي - حسب نوع الفحص
- عينة جراحية
- خزعة الثدي
- خزعة الرئة
- خزعة الكلى
- خزعة الجهاز الهضمي
- خزعة البنكرياس
- خزعة أنسجة الجلد
- خزعة الخصية
- أخرى
التشريح المرضي سوق الخدمات – بواسطة المستخدم النهائي
- المختبرات التشخيصية & المختبرات المرجعية
- معاهد البحوث
- أخرى
سوق خدمات التشريح المرضي - بواسطة الجغرافيا
- أمريكا الشمالية
- الولايات المتحدة
- كندا
- المكسيك
< li>أوروبا - فرنسا
- ألمانيا
- إيطاليا
- المملكة المتحدة
- إسبانيا
- الراحة أوروبا
- آسيا والمحيط الهادئ (APAC)
- الصين
- الهند
- كوريا الجنوبية
- اليابان
- أستراليا
- باقي دول آسيا والمحيط الهادئ
- الشرق الأوسط& أفريقيا (MEA)
- جنوب أفريقيا
- المملكة العربية السعودية
- الإمارات العربية المتحدة
- باقي دول الشرق الأوسط وأفريقيا أفريقيا
- أمريكا الجنوبية (SAM)
- البرازيل
- الأرجنتين
- باقي أمريكا الجنوبية والوسطى< /li>
الملفات التعريفية للشركة
- Sonic Healthcare Limited
- المختبر Corporation of America Holdings
- Acculabs Diagnostics UK Ltd
- TPL Path Labs
- UNILABS
- Cureline Global Translational CRO
- Targos
- خدمات علم الأمراض الخلوية،
- Experimental Pathology Laboratories Inc (EPL)
- CHARLES RIVER LABORATORIES, INC.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.
Key factors that are driving the growth of this market include rising demand for biologics and increasing prevalence of chronic diseases.
Global histopathology services market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for histopathology services. The US is estimated to hold the largest share in the histopathology services market during the forecast period. The growth of the market can be because of prevalence of various diseases, government support for biotechnology and increasing efforts in R&D activities as well as other activities undertaken by the market players operating in the market. In addition, technological advancements in the diagnosis industry is likely to stimulate the growth of histopathology services market in North America. On the other hand, large pool of population suffering with chronic diseases, rapidly developing healthcare infrastructure, and intellectual capabilities of scientists and researchers in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.
The surgical specimen segment dominated the global histopathology services market and held the largest revenue share of 48.51% in 2021.
The diagnostic laboratories and reference laboratories segment dominated the global histopathology services market and accounted for the largest revenue share of 71.74% in 2021.
The histopathology services market majorly consists of the players such Sonic Healthcare Limited, Laboratory Corporation of America Holdings, Acculabs Diagnostics UK Ltd, TPL Path Labs, UNILABS, Cureline Global Translational CRO, Targos, Cellular Pathology Services, Experimental Pathology Laboratories Inc (EPL), and CHARLES RIVER LABORATORIES, INC. among others.
The List of Companies - Histopathology Services Market
- Sonic Healthcare Limited
- Laboratory Corporation of America Holdings
- Acculabs Diagnostics UK Ltd
- TPL Path Labs
- UNILABS
- Cureline Global Translational CRO
- Targos
- Cellular Pathology Services,
- Experimental Pathology Laboratories Inc (EPL)
- CHARLES RIVER LABORATORIES, INC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Aug 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Aug 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Aug 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)